Anatomic Pathology Market Analysis and Forecast by Size, Share, Growth, Trends 2031

Anatomic Pathology Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product and Services [Services (Histopathology and Cytopathology), Instruments (Microtomes and Cryostat, Automatic Stainers, Tissue Processors, and Others), and Consumables], Application (Disease Diagnosis, Drug Discovery and Development, and Others), End User (Hospitals, Research Laboratories, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

  • Report Code : TIPRE00002999
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 178
Buy Now

Anatomic Pathology Market Forecast, Trends, Scope by 2031

Buy Now

The anatomic pathology market size is projected to reach US$ 53.27 billion by 2031 from US$ 30.22 billion in 2023. The market is expected to register a CAGR of 7.3% during 2023–2031. The integration of artificial intelligence and machine learning is likely to act as a future trend in the market.

Anatomic Pathology Market Analysis

Innovations in diagnostic techniques—including digital pathology, molecular diagnostics, and imaging technologies—enhance the accuracy and efficiency of pathology services, propelling the anatomic pathology market growth. An aging population is more susceptible to various diseases, leading to increased demand for pathology services for accurate diagnosis and treatment planning. In addition, increased awareness about health issues, robust screening programs contributing to early diagnosis, supportive regulatory frameworks, and favorable reimbursement policies are fueling the growth of the anatomic pathology market.

Anatomic Pathology Market Overview

India is expected to register the highest CAGR in the overall market. The National Cancer Registry Programme Report 2020 projected cancer cases in India to reach 14.61 million in 2022. The report also stated that the incidence of cancer is estimated to increase by 12.8% by 2025 compared to 2020. With the surging prevalence of cancer and advancements in healthcare infrastructure, government authorities in India are focusing on providing people with extended access to healthcare solutions. As per data by the Department for Promotion of Industry and Internal Trade (DPIIT), the inflow of foreign direct investments (FDIs) into the drugs and pharmaceuticals industry totaled US$ 17.74 billion from April 2000 to December 2020. Moreover, companies, organizations, governments, etc., make significant investments in diagnostic services and modern diagnostic facilities. Thus, such investments in the healthcare sector bolster the anatomic pathology market growth in India.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Anatomic Pathology Market: Strategic Insights

anatomic-pathology-market
Market Size Value inUS$ 22,800.20 Million in 2022
Market Size Value byUS$ 33,145.78 Million by 2028
Growth rateCAGR of 6.4% from 2022 to 2028
Forecast Period2022-2028
Base Year2022
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Anatomic Pathology Market Drivers and Opportunities

Increase in Prevalence of Cancer and Kidney Diseases

Anatomic pathology is useful in identifying abnormalities that can help diagnose diseases, such as autoimmune diseases, kidney and liver diseases, and cancer. Histopathology, which involves studying tissue changes caused by diseases, is a vital part of anatomic pathology. Cancer has a major impact on society across the world. The burden of cancer on healthcare systems is significantly increasing worldwide as it is among the leading causes of death. The World Health Organization (WHO) ranks cancer as the second-leading cause of mortality worldwide. According to data published by the World Cancer Research Fund International, ~20 million new cases of cancer were registered in 2022 globally. Moreover, as per the data published by the World Health Organization (WHO), nearly 10 million deaths worldwide were caused by cancer in 2020. The National Center for Health Statistics data estimates that the diagnosis of new cancer cases in the US is likely to reach 2 million in 2024. In addition, ~0.61 million people are likely to die in 2024 in the US due to cancer. According to data published by Macmillan Cancer Support, ~392,000 people in the UK are diagnosed with cancer every year, while ~167,000 people die due to the disease each year.

The prevalence of chronic kidney disease is growing due to the increase in the geriatric population. According to the Centers for Disease Control and Prevention, in 2023, ~35.5 million people in the US suffered from chronic kidney diseases. Biopsy, an anatomic pathology technique, is used for the detection of cancer and chronic kidney disease. Owing to the increasing prevalence of cancer and kidney disease, government agencies, healthcare providers, and institutions are being compelled to contribute toward disease diagnosis and treatment initiatives. Thus, a surge in the prevalence of cancer and other targeted diseases, such as autoimmune diseases, and kidney and liver diseases is driving the global anatomic pathology market growth.

Growing Focus on Personalized Medicines to Offer Opportunity for Market

Personalized medicines are mainly designed by considering individuals' genetic profiles to guide the decisions made with respect to the prevention, diagnosis, and treatment of a disease. They provide an opportunity for drug manufacturers to develop agents that target patient groups that do not respond to medications as intended or for them who do not respond as expected to traditional healthcare practices. There is much evidence indicating that a substantial portion of the variability in drug response depends on factors that are genetically controlled, including age, nutrition, environmental exposure, and health status. Genomics plays an important role in the emergence of personalized medicines, as having the knowledge of a patient's genetic profile would help doctors in selecting an apt medication. Personalized medicines are helpful in improving healthcare by enabling each patient to receive earlier diagnoses, risk assessments, and optimal treatments.

Pathologists play an important role in developing and implementing molecular and genomic tests in practice. Personalized medicines are used in the treatment of diseases such as breast cancer and cardiovascular diseases. Personalized anticancer medicines exhibit fewer and less severe side effects than other types of treatment as they are designed for more specific action. Further, with the ongoing progress in research and clinical studies, personalized medicines are likely to reach even greater potential to improve the quality of patient care. Thus, the growing focus on personalized medicines is expected to boost the anatomic pathology market growth.

Anatomic Pathology Market Report Segmentation Analysis

Key segments that contributed to the derivation of the anatomic pathology market analysis are products and services, application, and end user.

  • Based on products and services, the anatomic pathology market is segmented into instruments, consumables, and services. The services segment is further bifurcated into histopathology and cytopathology. The instruments segment is further divided into microtomes and cryostat, automatic stainers, tissue processors, and others. The instruments segment held the largest market share in 2023.
  • By application, the market is segmented into disease diagnosis, drug discovery and development, and others. The disease diagnosis segment held the largest market share in 2023.
  • Based on end user, the anatomic pathology market is divided into hospitals, research laboratories, diagnostic laboratories, and others. The hospitals segment held the largest market share in 2023.

Anatomic Pathology Market Share Analysis by Geography

The geographic scope of the anatomic pathology market report is mainly divided into five regions: North America, Asia Pacific, Europe, the South & Central America, and the Middle East & Africa. North America dominated the market in 2023. The growth of the market in this region is attributed to the growing prevalence of cancer, increasing government initiatives for screening cancer patients, rising focus on efficient disease diagnosis, and surging need for advanced healthcare systems. Moreover, increased research and development efforts undertaken by the market players, coupled with product launches, are likely to drive the growth of the anatomic pathology market in North America during the forecast period. Players operating in the US anatomic pathology market continuously focus on the development of innovative and convenient instruments and consumables for pathological procedures. In November 2023, Illumina Inc., US, a global leader in DNA sequencing and array-based technologies, introduced TruSight Oncology 500 ctDNA v2 (plate number 1 ctDNA v2), a new version of its distributed liquid biopsy assay that allows comprehensive noninvasive genomic profiling of circulating tumor DNA from blood, complementing tissue-based testing. Asia Pacific is anticipated to register the highest CAGR during the forecast period.

Anatomic Pathology Market Report Scope

Anatomic Pathology Market News and Recent Developments

The anatomic pathology market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:

  • Agilent Technologies Inc. partnered with Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems. The collaboration involved incorporating Hamamatsu's NanoZoomer range, including the S360MD Slide scanner system, into Agilent's digital pathology solution. The addition of the NanoZoomer Slide scanner systems, which convert glass slides into high-resolution digital data through high-speed scanning, has completed Agilent's offering of an open and agnostic digital pathology workflow aimed at accelerating breakthroughs in precision medicine. (Source: Agilent Technologies Inc., Company Website, March 2023)
  • Epredia, a subsidiary of PHC Corporation, and NovaScan, Inc., a company that develops breakthrough technology for cancer detection and stratification, announced signing a letter of intent for a U.S. exclusive commercial distribution agreement for MarginScan, a medical device that will support physicians in real-time detection of non-melanoma skin cancer. Epredia has engaged Avantik, a company specializing in supporting diagnostic labs with their operations, to get this new device into the hands of Mohs surgeons. (Source: PHC Corporation, Company Website, May 2024)

Anatomic Pathology Market Report Coverage and Deliverables

The "Anatomic Pathology Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

  • Anatomic pathology market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Anatomic pathology market trends, as well as market dynamics such as drivers, restraints, and key opportunities
  • Detailed PESTand SWOT analysis
  • Anatomic pathology market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the anatomic pathology market
  • Detailed company profiles
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product and Service, Application, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What would be the estimated value of the anatomic pathology market by 2031?

The anatomic pathology market value is expected to reach US$ 53.27 billion by 2031.

What is the expected CAGR of the anatomic pathology market?

The market is expected to register a CAGR of 7.3% during 2023–2031.

Which product and service led the anatomic pathology market?

The services segment dominated the global anatomic pathology market and held the largest revenue share of 40.04% in 2021.

Which are the leading players operating in the anatomic pathology market?

F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, BD, and PHC Holdings Corporation are among the key players in the market.

What are the future trends of the anatomic pathology market?

The integration of artificial intelligence and machine learning is expected to be a prime trend in the market in the coming years.

Which region dominated the anatomic pathology market in 2023?

North America dominated the market in 2023.

What are the driving factors impacting the anatomic pathology market?

The increase in the prevalence of cancer and kidney diseases and the rise in the number of strategic initiatives are among the most significant factors fueling the market growth.

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

4. Anatomic Pathology Market Landscape

4.1 Overview

4.2 PEST Analysis

5. Anatomic Pathology Market – Key Market Dynamics

5.1 Anatomic Pathology Market – Key Market Dynamics

5.2 Market Drivers

5.2.1 Increase in Prevalence of Cancer and Kidney Diseases

5.2.2 Rise in Number of Strategic Initiatives

5.3 Market Restraints

5.3.1 Lack of Skilled Professionals

5.3.2 Stringent Government Regulations

5.4 Market Opportunities

5.4.1 Growing Focus on Personalized Medicines

5.5 Future Trends

5.5.1 Integration of Artificial Intelligence and Machine Learning

5.6 Impact of Drivers and Restraints:

6. Anatomic Pathology Market – Global Market Analysis

6.1 Anatomic Pathology Market Revenue (US$ Million), 2021–2031

6.2 Anatomic Pathology Market Forecast Analysis

7. Anatomic Pathology Market Analysis – by Product and Services

7.1 Services

7.1.1 Overview

7.1.2 Services: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Instruments

7.2.1 Overview

7.2.2 Instruments: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Consumables

7.3.1 Overview

7.3.2 Consumables: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

8. Anatomic Pathology Market Analysis – by Application

8.1 Disease Diagnosis

8.1.1 Overview

8.1.2 Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

8.2 Drug Discovery and Development

8.2.1 Overview

8.2.2 Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

8.3 Others

8.3.1 Overview

8.3.2 Others: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

9. Anatomic Pathology Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview

9.1.2 Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

9.2 Research Laboratories

9.2.1 Overview

9.2.2 Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

9.3 Diagnostic Laboratories

9.3.1 Overview

9.3.2 Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

9.4 Others

9.4.1 Overview

9.4.2 Others: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10. Anatomic Pathology Market – Geographical Analysis

10.1 Overview

10.2 North America

10.2.1 North America Anatomic Pathology Market Overview

10.2.2 North America: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services

10.2.4 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services

10.2.5 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments

10.2.6 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application

10.2.7 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User

10.2.8 North America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country

10.2.8.1 United States: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.2.8.1.1 United States: Anatomic Pathology Market Breakdown, by Product and Services

10.2.8.1.1.1 United States: Anatomic Pathology Market Breakdown, by Services

10.2.8.1.1.2 United States: Anatomic Pathology Market Breakdown, by Instruments

10.2.8.1.2 United States: Anatomic Pathology Market Breakdown, by Application

10.2.8.1.3 United States: Anatomic Pathology Market Breakdown, by End User

10.2.8.2 Canada: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.2.8.2.1 Canada: Anatomic Pathology Market Breakdown, by Product and Services

10.2.8.2.1.1 Canada: Anatomic Pathology Market Breakdown, by Services

10.2.8.2.1.2 Canada: Anatomic Pathology Market Breakdown, by Instruments

10.2.8.2.2 Canada: Anatomic Pathology Market Breakdown, by Application

10.2.8.2.3 Canada: Anatomic Pathology Market Breakdown, by End User

10.2.8.3 Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.2.8.3.1 Mexico: Anatomic Pathology Market Breakdown, by Product and Services

10.2.8.3.1.1 Mexico: Anatomic Pathology Market Breakdown, by Services

10.2.8.3.1.2 Mexico: Anatomic Pathology Market Breakdown, by Instruments

10.2.8.3.2 Mexico: Anatomic Pathology Market Breakdown, by Application

10.2.8.3.3 Mexico: Anatomic Pathology Market Breakdown, by End User

10.3 Europe

10.3.1 Europe Anatomic Pathology Market Overview

10.3.2 Europe: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.3.3 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services

10.3.4 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services

10.3.5 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments

10.3.6 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application

10.3.7 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User

10.3.8 Europe: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country

10.3.8.1 United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.3.8.1.1 United Kingdom: Anatomic Pathology Market Breakdown, by Product and Services

10.3.8.1.1.1 United Kingdom: Anatomic Pathology Market Breakdown, by Services

10.3.8.1.1.2 United Kingdom: Anatomic Pathology Market Breakdown, by Instruments

10.3.8.1.2 United Kingdom: Anatomic Pathology Market Breakdown, by Application

10.3.8.1.3 United Kingdom: Anatomic Pathology Market Breakdown, by End User

10.3.8.2 Germany: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.3.8.2.1 Germany: Anatomic Pathology Market Breakdown, by Product and Services

10.3.8.2.1.1 Germany: Anatomic Pathology Market Breakdown, by Services

10.3.8.2.1.2 Germany: Anatomic Pathology Market Breakdown, by Instruments

10.3.8.2.2 Germany: Anatomic Pathology Market Breakdown, by Application

10.3.8.2.3 Germany: Anatomic Pathology Market Breakdown, by End User

10.3.8.3 France: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.3.8.3.1 France: Anatomic Pathology Market Breakdown, by Product and Services

10.3.8.3.1.1 France: Anatomic Pathology Market Breakdown, by Services

10.3.8.3.1.2 rance: Anatomic Pathology Market Breakdown, by Instruments

10.3.8.3.2 France: Anatomic Pathology Market Breakdown, by Application

10.3.8.3.3 France: Anatomic Pathology Market Breakdown, by End User

10.3.8.4 Italy: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.3.8.4.1 Italy: Anatomic Pathology Market Breakdown, by Product and Services

10.3.8.4.1.1 Italy: Anatomic Pathology Market Breakdown, by Services

10.3.8.4.1.2 Italy: Anatomic Pathology Market Breakdown, by Instruments

10.3.8.4.2 Italy: Anatomic Pathology Market Breakdown, by Application

10.3.8.4.3 Italy: Anatomic Pathology Market Breakdown, by End User

10.3.8.5 Spain: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.3.8.5.1 Spain: Anatomic Pathology Market Breakdown, by Product and Services

10.3.8.5.1.1 Spain: Anatomic Pathology Market Breakdown, by Services

10.3.8.5.1.2 Spain: Anatomic Pathology Market Breakdown, by Instruments

10.3.8.5.2 Spain: Anatomic Pathology Market Breakdown, by Application

10.3.8.5.3 Spain: Anatomic Pathology Market Breakdown, by End User

10.3.8.6 Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.3.8.6.1 Rest of Europe: Anatomic Pathology Market Breakdown, by Product and Services

10.3.8.6.1.1 Rest of Europe: Anatomic Pathology Market Breakdown, by Services

10.3.8.6.1.2 Rest of Europe: Anatomic Pathology Market Breakdown, by Instruments

10.3.8.6.2 Rest of Europe: Anatomic Pathology Market Breakdown, by Application

10.3.8.6.3 Rest of Europe: Anatomic Pathology Market Breakdown, by End User

10.4 Asia Pacific

10.4.1 Asia Pacific Anatomic Pathology Market Overview

10.4.2 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.4.3 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services

10.4.4 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services

10.4.5 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments

10.4.6 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application

10.4.7 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User

10.4.8 Asia Pacific: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country

10.4.8.1 China: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.4.8.1.1 China: Anatomic Pathology Market Breakdown, by Product and Services

10.4.8.1.1.1 China: Anatomic Pathology Market Breakdown, by Services

10.4.8.1.1.2 China: Anatomic Pathology Market Breakdown, by Instruments

10.4.8.1.2 China: Anatomic Pathology Market Breakdown, by Application

10.4.8.1.3 China: Anatomic Pathology Market Breakdown, by End User

10.4.8.2 Japan: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.4.8.2.1 Japan: Anatomic Pathology Market Breakdown, by Product and Services

10.4.8.2.1.1 Japan: Anatomic Pathology Market Breakdown, by Services

10.4.8.2.1.2 Japan: Anatomic Pathology Market Breakdown, by Instruments

10.4.8.2.2 Japan: Anatomic Pathology Market Breakdown, by Application

10.4.8.2.3 Japan: Anatomic Pathology Market Breakdown, by End User

10.4.8.3 India: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.4.8.3.1 India: Anatomic Pathology Market Breakdown, by Product and Services

10.4.8.3.1.1 India: Anatomic Pathology Market Breakdown, by Services

10.4.8.3.1.2 India: Anatomic Pathology Market Breakdown, by Instruments

10.4.8.3.2 India: Anatomic Pathology Market Breakdown, by Application

10.4.8.3.3 India: Anatomic Pathology Market Breakdown, by End User

10.4.8.4 Australia: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.4.8.4.1 Australia: Anatomic Pathology Market Breakdown, by Product and Services

10.4.8.4.1.1 Australia: Anatomic Pathology Market Breakdown, by Services

10.4.8.4.1.2 Australia: Anatomic Pathology Market Breakdown, by Instruments

10.4.8.4.2 Australia: Anatomic Pathology Market Breakdown, by Application

10.4.8.4.3 Australia: Anatomic Pathology Market Breakdown, by End User

10.4.8.5 South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.4.8.5.1 South Korea: Anatomic Pathology Market Breakdown, by Product and Services

10.4.8.5.1.1 South Korea: Anatomic Pathology Market Breakdown, by Services

10.4.8.5.1.2 South Korea: Anatomic Pathology Market Breakdown, by Instruments

10.4.8.5.2 South Korea: Anatomic Pathology Market Breakdown, by Application

10.4.8.5.3 South Korea: Anatomic Pathology Market Breakdown, by End User

10.4.8.6 Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.4.8.6.1 Rest of APAC: Anatomic Pathology Market Breakdown, by Product and Services

10.4.8.6.1.1 Rest of APAC: Anatomic Pathology Market Breakdown, by Services

10.4.8.6.1.2 Rest of APAC: Anatomic Pathology Market Breakdown, by Instruments

10.4.8.6.2 Rest of APAC: Anatomic Pathology Market Breakdown, by Application

10.4.8.6.3 Rest of APAC: Anatomic Pathology Market Breakdown, by End User

10.5 Middle East and Africa

10.5.1 Middle East and Africa Anatomic Pathology Market Overview

10.5.2 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.5.3 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services

10.5.4 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services

10.5.5 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments

10.5.6 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application

10.5.7 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User

10.5.8 Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country

10.5.8.1 South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.5.8.1.1 South Africa: Anatomic Pathology Market Breakdown, by Product and Services

10.5.8.1.1.1 South Africa: Anatomic Pathology Market Breakdown, by Services

10.5.8.1.1.2 South Africa: Anatomic Pathology Market Breakdown, by Instruments

10.5.8.1.2 South Africa: Anatomic Pathology Market Breakdown, by Application

10.5.8.1.3 South Africa: Anatomic Pathology Market Breakdown, by End User

10.5.8.2 Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.5.8.2.1 Saudi Arabia: Anatomic Pathology Market Breakdown, by Product and Services

10.5.8.2.1.1 Saudi Arabia: Anatomic Pathology Market Breakdown, by Services

10.5.8.2.1.2 Saudi Arabia: Anatomic Pathology Market Breakdown, by Instruments

10.5.8.2.2 Saudi Arabia: Anatomic Pathology Market Breakdown, by Application

10.5.8.2.3 Saudi Arabia: Anatomic Pathology Market Breakdown, by End User

10.5.8.3 United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.5.8.3.1 United Arab Emirates: Anatomic Pathology Market Breakdown, by Product and Services

10.5.8.3.1.1 United Arab Emirates: Anatomic Pathology Market Breakdown, by Services

10.5.8.3.1.2 United Arab Emirates: Anatomic Pathology Market Breakdown, by Instruments

10.5.8.3.2 United Arab Emirates: Anatomic Pathology Market Breakdown, by Application

10.5.8.3.3 United Arab Emirates: Anatomic Pathology Market Breakdown, by End User

10.5.8.4 Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.5.8.4.1 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Product and Services

10.5.8.4.1.1 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Services

10.5.8.4.1.2 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Instruments

10.5.8.4.2 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by Application

10.5.8.4.3 Rest of Middle East and Africa: Anatomic Pathology Market Breakdown, by End User

10.6 South and Central America

10.6.1 South and Central America Anatomic Pathology Market Overview

10.6.2 South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.6.3 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Product and Services

10.6.4 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Services

10.6.5 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Instruments

10.6.6 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Application

10.6.7 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by End User

10.6.8 South and Central America: Anatomic Pathology Market – Revenue and Forecast Analysis – by Country

10.6.8.1 Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.6.8.1.1 Brazil: Anatomic Pathology Market Breakdown, by Product and Services

10.6.8.1.1.1 Brazil: Anatomic Pathology Market Breakdown, by Services

10.6.8.1.1.2 Brazil: Anatomic Pathology Market Breakdown, by Instruments

10.6.8.1.2 Brazil: Anatomic Pathology Market Breakdown, by Application

10.6.8.1.3 Brazil: Anatomic Pathology Market Breakdown, by End User

10.6.8.2 Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.6.8.2.1 Argentina: Anatomic Pathology Market Breakdown, by Product and Services

10.6.8.2.1.1 Argentina: Anatomic Pathology Market Breakdown, by Services

10.6.8.2.1.2 Argentina: Anatomic Pathology Market Breakdown, by Instruments

10.6.8.2.2 Argentina: Anatomic Pathology Market Breakdown, by Application

10.6.8.2.3 Argentina: Anatomic Pathology Market Breakdown, by End User

10.6.8.3 Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

10.6.8.3.1 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Product and Services

10.6.8.3.1.1 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Services

10.6.8.3.1.2 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Instruments

10.6.8.3.2 Rest of South and Central America: Anatomic Pathology Market Breakdown, by Application

10.6.8.3.3 Rest of South and Central America: Anatomic Pathology Market Breakdown, by End User

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in Anatomic Pathology Market

11.3 Organic Growth Strategies

11.3.1 Overview

11.4 Inorganic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Beckman Coulter Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Hologic Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Agilent Technologies Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 BioGenex Laboratories Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Diapath S.p.A.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Bio SB

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Merck KGaA

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 PHC Holdings Corporation

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

13. Appendix

13.1 About Us

13.2 Glossary of Terms

List of Tables

Table 1. Anatomic Pathology Market Segmentation

Table 2. Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

Table 3. Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million) – by Product and Services

Table 4. Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million) – by Application

Table 5. Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 6. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 7. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 8. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 9. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 10. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 11. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 12. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 13. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 14. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 15. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 16. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 17. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 18. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 19. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 20. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 21. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 22. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 23. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 24. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 25. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 26. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 27. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 28. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 29. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 30. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 31. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 32. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 33. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 34. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 35. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 36. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 37. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 38. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 39. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 40. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 41. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 42. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 43. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 44. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 45. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 46. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 47. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 48. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 49. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 50. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 51. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 52. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 53. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 54. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 55. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 56. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 57. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 58. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 59. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 60. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 61. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 62. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 63. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 64. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 65. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 66. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 67. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 68. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 69. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 70. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 71. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 72. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 73. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 74. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 75. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 76. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 77. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 78. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 79. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 80. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 81. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 82. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 83. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 84. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 85. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 86. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 87. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 88. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 89. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 90. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 91. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 92. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 93. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 94. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 95. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 96. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 97. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 98. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 99. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 100. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 101. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 102. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 103. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 104. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 105. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 106. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 107. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 108. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 109. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 110. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 111. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 112. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 113. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 114. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 115. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 116. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 117. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 118. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 119. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 120. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 121. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 122. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 123. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 124. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 125. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 126. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 127. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 128. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 129. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 130. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 131. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 132. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 133. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 134. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 135. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 136. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Product and Services

Table 137. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Services

Table 138. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Instruments

Table 139. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 140. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 141. Recent Organic Growth Strategies in Anatomic Pathology Market

Table 142. Recent Inorganic Growth Strategies in the Anatomic Pathology Market

Table 143. Glossary of Terms, Anatomic Pathology Market

List of Figures

Figure 1. Anatomic Pathology Market Segmentation, by Geography

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Anatomic Pathology Market Revenue (US$ Million), 2021–2031

Figure 5. Anatomic Pathology Market Share (%) – by Product and Services (2023 and 2031)

Figure 6. Services: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7. Instruments: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8. Consumables: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9. Anatomic Pathology Market Share (%) – by Application (2023 and 2031)

Figure 10. Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11. Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12. Others: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

Figure 13. Anatomic Pathology Market Share (%) – by End User (2023 and 2031)

Figure 14. Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15. Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16. Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17. Others: Anatomic Pathology Market – Revenue and Forecast to 2031 (US$ Million)

Figure 18. Anatomic Pathology Market Breakdown by Region, 2023 and 2031 (%)

Figure 19. North America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 20. North America: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 21. United States: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 22. Canada: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 23. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 24. Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 25. Europe: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 26. United Kingdom: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 27. Germany: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 28. France: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 29. Italy: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 30. Spain: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 31. Rest of Europe: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 32. Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 33. Asia Pacific: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 34. China: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 35. Japan: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 36. India: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 37. Australia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 38. South Korea: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 39. Rest of APAC: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 40. Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 41. Middle East and Africa: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 42. South Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 43. Saudi Arabia: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 44. United Arab Emirates: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 45. Rest of Middle East and Africa: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 46. South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 47. South and Central America: Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 48. Brazil: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 49. Argentina: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 50. Rest of South and Central America: Anatomic Pathology Market – Revenue and Forecast to 2031(US$ Million)

Figure 51. Growth Strategies in Anatomic Pathology Market

The List of Companies - Anatomic Pathology Market

  1. F. Hoffmann-La Roche Ltd
  2. Beckman Coulter Inc
  3. Hologic Inc
  4. Agilent Technologies Inc
  5. BioGenex Laboratories Inc
  6. Diapath S.p.A.
  7. Bio SB
  8. Merck KGaA
  9. BD
  10. PHC Holdings Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Anatomic Pathology Market